Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (261-270 of 496) with videos related to

Pageof 50
Sort By:
Neuroscience Letters|June 12, 1981
The influence of foot-shock stress upon brain, pituitary and spinal cord pools of immunoreactive dynorphin in ratsM J Millan, Y F Tsang, R Prezewłocki, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1984
Preliminary evidence of natural resistance to Mycobacterium bovis (BCG) in lepromatous leprosyJ L Stach, G Delgado, M Strobel, et al.
Parkinsonism & Related Disorders|July 1, 2008
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formationRoberto Maggio, Francesca Novi, Mario Rossi, et al.
Acta Leprologica|January 1, 1989
[Lepromatous leprosy: clinical and electrophysiological arguments in favor of axonal multi-neuritis]C Tzourio, P Henry, P Boucher, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptorsC Stein, M J Millan, T S Shippenberg, et al.
Pain|November 1, 1988
Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonistsT S Shippenberg, C Stein, A Huber, et al.
Journal of Neurochemistry|December 31, 1997
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving ratsA Gobert, J M Rivet, L Cistarelli, et al.
Neuroscience Applied|July 14, 2025
Prospects for improved prevention and treatment of neuropsychiatric disorders: <i>Neuroscience Applied</i>Andreas Meyer-Lindenberg, Suzanne L Dickson, Mark J Millan, et al.
Neuropharmacology|December 1, 1995
[3H](+)S 14297: a novel, selective radioligand at cloned human dopamine D3 receptorsA Newman-Tancredi, V Audinot, V Jacques, et al.
Psychopharmacology|November 10, 2001
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in ratsA Dekeyne, A Gobert, L Iob, et al.
Pageof 50

Showing results (261-270 of 496) with videos related to

Sort By:
Pageof 50
Neuroscience Letters|June 12, 1981
The influence of foot-shock stress upon brain, pituitary and spinal cord pools of immunoreactive dynorphin in ratsM J Millan, Y F Tsang, R Prezewłocki, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1984
Preliminary evidence of natural resistance to Mycobacterium bovis (BCG) in lepromatous leprosyJ L Stach, G Delgado, M Strobel, et al.
Parkinsonism & Related Disorders|July 1, 2008
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formationRoberto Maggio, Francesca Novi, Mario Rossi, et al.
Acta Leprologica|January 1, 1989
[Lepromatous leprosy: clinical and electrophysiological arguments in favor of axonal multi-neuritis]C Tzourio, P Henry, P Boucher, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptorsC Stein, M J Millan, T S Shippenberg, et al.
Pain|November 1, 1988
Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonistsT S Shippenberg, C Stein, A Huber, et al.
Journal of Neurochemistry|December 31, 1997
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving ratsA Gobert, J M Rivet, L Cistarelli, et al.
Neuroscience Applied|July 14, 2025
Prospects for improved prevention and treatment of neuropsychiatric disorders: <i>Neuroscience Applied</i>Andreas Meyer-Lindenberg, Suzanne L Dickson, Mark J Millan, et al.
Neuropharmacology|December 1, 1995
[3H](+)S 14297: a novel, selective radioligand at cloned human dopamine D3 receptorsA Newman-Tancredi, V Audinot, V Jacques, et al.
Psychopharmacology|November 10, 2001
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in ratsA Dekeyne, A Gobert, L Iob, et al.
Pageof 50